News and Trends 7 Nov 2019
€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics
…underpinnings of rare diseases using genomics and epidemiology. The company uses the data to find genes and biomarkers linked to conditions that its partner companies are interested in. Centogene specializes…